Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma
Open Access
- 15 June 1996
- Vol. 77 (12) , 2574-2580
- https://doi.org/10.1002/(sici)1097-0142(19960615)77:12<2574::aid-cncr22>3.3.co;2-s
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: